Generac executive sells shares after option exercise

GENERAC HOLDINGS INC. executive Norman P. Taffe, President Generac Home, reported option-related trades in company stock.

Filing Impact

(High)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

GENERAC HOLDINGS INC. executive Norman P. Taffe, President Generac Home, reported option-related trades in company stock. On June 5, 2026, he exercised stock options to acquire 250 shares of common stock at $119.54 per share and sold 550 shares in open-market transactions at $272.26 per share. These trades were made under a Rule 10b5-1(c) trading plan adopted on March 6, 2026. After the transactions, he directly holds 16,108 shares of Generac common stock and retains 2,970 stock options exercisable at $119.54 per share, expiring on March 1, 2033.

Insider Trade Summary 10b5-1

Exercise and sale activity reported; no spread calculated

Exercise and Sale 8 txns

Insider Taffe Norman P

Role President Generac Home

Sold 550 shs ($150K)

Approx. gross sale proceeds $150K

Approx. exercise cost $30K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	150	$0.00	$0.00
Exercise	Stock Option (Right to Buy)	100	$0.00	$0.00
Sale	Common Stock	200	$272.26	$54K
Sale	Common Stock	100	$272.26	$27K
Exercise	Common Stock	150	$119.54	$18K
Sale	Common Stock	150	$272.26	$41K
Exercise	Common Stock	100	$119.54	$12K
Sale	Common Stock	100	$272.26	$27K

Holdings After Transaction: Stock Option (Right to Buy) — 2,870 contracts (Direct); Common Stock — 16,108 shares (Direct)

Footnotes (3)

F1. Adoption date of referenced 10b5-1(c) plan is: 03-06-2026
F2. Multiple lots for the same price for this order have been combined.
F3. Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche.

Key Figures

Shares sold: 550 shares Sale price: $272.26 per share Options exercised: 250 shares +4 more

7 metrics

Shares sold 550 shares Open-market sales of Generac common stock on June 5, 2026 at $272.26

Sale price $272.26 per share Price for 550 Generac common shares sold on June 5, 2026

Options exercised 250 shares Common shares acquired via option exercises on June 5, 2026

Option exercise price $119.54 per share Exercise price for stock options converted into 250 common shares

Post-transaction holdings 16,108 shares Direct Generac common stock holdings after June 5, 2026 trades

Remaining stock options 2,970 options at $119.54 Outstanding options expiring March 1, 2033 following exercises

10b5-1 plan adoption date March 6, 2026 Adoption date of Rule 10b5-1(c) trading plan governing the trades

Key Terms

Rule 10b5-1(c) plan, open-market sale, Stock Option (Right to Buy), graded vesting schedule

4 terms

Rule 10b5-1(c) plan regulatory

"Adoption date of referenced 10b5-1(c) plan is: 03-06-2026"

open-market sale financial

"transaction_action: "open-market sale" with price $272.2600 per share"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)" with exercise price 119.5400"

graded vesting schedule financial

"Grant has a graded vesting schedule. Date exercisable will vary"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Generac (GNRC) executive Norman P. Taffe report?

Norman P. Taffe reported exercising stock options for 250 Generac shares and selling 550 shares in open-market trades. All transactions occurred on June 5, 2026 and were linked to previously granted compensation-related stock options.

How many Generac (GNRC) shares did Norman P. Taffe sell and at what price?

Norman P. Taffe sold 550 shares of Generac common stock at an average price of $272.26 per share. These open-market sales were disclosed as standard transactions and occurred on June 5, 2026 according to the Form 4 filing.

What stock options did Norman P. Taffe exercise in this Generac (GNRC) Form 4?

He exercised stock options covering 250 shares of Generac common stock at an exercise price of $119.54 per share. These options are part of a grant with a graded vesting schedule, and the remaining options continue to be exercisable until March 1, 2033.

How many Generac (GNRC) shares does Norman P. Taffe own after these transactions?

Following the reported transactions, Norman P. Taffe directly owns 16,108 shares of Generac common stock. In addition, he holds 2,970 stock options with a $119.54 exercise price that remain outstanding and unexercised after the June 5, 2026 activity.

Were Norman P. Taffe’s Generac (GNRC) stock sales made under a 10b5-1 plan?

Yes. A footnote states the trades were under a Rule 10b5-1(c) trading plan adopted on March 6, 2026. Such plans allow pre-scheduled transactions, which can indicate the timing of sales was arranged in advance rather than decided opportunistically.

What is the significance of the remaining Generac (GNRC) stock options held by Norman P. Taffe?

After exercising some options, Norman P. Taffe still holds 2,970 stock options exercisable at $119.54 per share until March 1, 2033. These options represent additional potential future share acquisitions tied to his existing Generac equity compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/08/2026 - 05:30 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Taffe Norman P

(Last)

(First)

(Middle)

S45 W29290 HWY.59

C/O GENERAC HOLDINGS INC.

(Street)

WAUKESHA

WISCONSIN

53189

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GENERAC HOLDINGS INC. [ GNRC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President Generac Home

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/05/2026		S⁽¹⁾⁽²⁾		200	D	$272.26	16,208	D
Common Stock	06/05/2026		S⁽¹⁾		100	D	$272.26	16,108	D
Common Stock	06/05/2026		M⁽¹⁾		150	A	$119.54	16,258	D
Common Stock	06/05/2026		S⁽¹⁾⁽²⁾		150	D	$272.26	16,108	D
Common Stock	06/05/2026		M⁽¹⁾		100	A	$119.54	16,208	D
Common Stock	06/05/2026		S⁽¹⁾⁽²⁾		100	D	$272.26	16,108	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$119.54	06/05/2026		M			150	⁽³⁾	03/01/2033	Common Stock	150	$0	2,970	D
Stock Option (Right to Buy)	$119.54	06/05/2026		M			100	⁽³⁾	03/01/2033	Common Stock	100	$0	2,870	D

Explanation of Responses:

1. Adoption date of referenced 10b5-1(c) plan is: 03-06-2026

2. Multiple lots for the same price for this order have been combined.

3. Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche.

	/s/ Raj Kanuru, Attorney in Fact	06/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR